Both in Biotechnology
Iovance Biotherapeutics vs Beam Therapeutics
Over the past year IOVA returned +330.5% and BEAM returned +8.9%; their daily moves had a correlation of 0.30.
IOVA +330.5% BEAM +8.9%Growth of $1, one year, split-adjusted
| Metric | IOVA | BEAM |
|---|---|---|
| Price | $8.48 | $27.23 |
| Market cap | $3.84B | $2.81B |
| Today | −11.30% | −5.58% |
| 1 month | −40.4% | +11.6% |
| 6 months | +149.4% | −11.3% |
| Year to date | +210.6% | −1.8% |
| 1 year | +324.0% | +9.9% |
| Revenue growth (YoY) | +65.7% | −94.2% |
| Gross margin | 56.1% | 100.0% |
| Net margin | −47.6% | −25036.3% |
| P/E (TTM) | — | — |
| Price / sales | 11.8× | 18.0× |
| Net cash | $297.7M | $1.05B |
| Dividend yield | — | — |
| Volatility (60d) | 128.2% | 62.4% |
| Short % of float | 15.2% | 32.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).